Acute Coronary Syndromes
New statement on cocaine-associated MI urges caution with beta blockers, emphasizes kicking the habit
March 17, 2008 | Shelley Wood

Dallas, TX - People admitted to the hospital with chest pain or MI associated with cocaine use should be treated much the same as any other patient with "traditional" ACS, but with the addition of intravenous benzodiazepines and a cautionary approach to beta blockers, a new American Heart Association (AHA) statement recommends. According to the writing group, led by Dr Jim McCord (Henry Ford Hospital, Detroit, MI), benzodiazepines relieve chest pain and have beneficial cardiac hemodynamic effects; they are a class 1 recommendation in the statement, with a B level of evidence.

McCord et al write that cocaine accounts for more than 100 000 emergency-department visits in the US each year, with chest pain being one of the most common complaints. The authors also point out that cocaine-related emergency-department visits rose by almost 50% between 1999 and 2002, suggesting that the number of people coming to the emergency room with cocaine-associated chest pain "will likely be increasing."

Cocaine has multiple effects on the heart, including driving up blood pressure, heart rate, and contractility, the authors note. It also has vasoconstrictive effects on the coronary arteries and is associated with increased platelet count, increased platelet activation, and platelet hyperaggregability.

While the full pathological effects of cocaine are unknown, researchers believe cocaine-induced MI appears to occur soon after ingestion, usually within the first few hours, although other studies suggest that, particularly in chronic users, ischemia can occur many hours or even days after cocaine use. In their statement, the AHA writing group emphasizes that self-reporting should be the primary means of establishing a role for cocaine use in a chest-pain patient, but that, given the reluctance to admit to cocaine use, urine tests may sometimes be necessary.

McCord et al also suggest that the evaluation and management of a patient with cocaine-induced chest pain or MI should be similar to the approach recommended in someone with no history of cocaine use, with the important exception of adding benzodiazepines. Evidence also suggests that beta blockers should be avoided in the acute phase, given the propensity of some of these agents to worsen coronary artery vasoconstriction and increase blood pressure. Indeed, given the high number of cocaine users who continue to use the drug even after an MI, physicians may need to avoid beta blockers even for the long-term management of patients with coronary artery disease.

For this reason and others, McCord and colleagues emphasize that cessation of cocaine use "should be the primary goal of secondary prevention."

Source
  1. McCord J, Cercek B, de Lemos J, et al. Management of cocaine-associated chest pain and myocardial infarction. Circulation 2008; DOI: 10.1161/CIRCULATIONAHA.107.188950. Available at: http://circ.ahajournals.org.




You have to be logged in to add a comment to this article
Login
Username 
Password 
  Forgot your password?
 
Remember me on this computer
 
Join theheart.org community
Five reasons to become a member of the most trusted source of cardiology news:
1Be part of the conversation in our blogs and discussion forum
2Share your thoughts on our news or educational programs
3Receive exclusive newsletters related to your field of interest
4Access unique continuous medical education content
5See and read what leaders have to say about cardiology today
It is free and it only takes five minutes to join!
 
button
Previews
Featured CME
Inside: Acute Coronary Syndromes
Acute Coronary Syndromes
Jun 22, 2009 00:07 EDT
Early-ACS, HORIZONS-AMI, On-TIME 2... How do you use GP IIb/IIIa inhibitors in contemporary practice? Given the continued uncertainty regarding the optimal duration of dual antiplatelet therapy, what do you do for AF patients on warfarin who need stents? Answer our 3 short polling questions and learn your peers' responses.
Acute Coronary Syndromes
Jun 12, 2009 15:10 EDT
Studies suggest that major bleeding is associated with a 5-fold increase in the risk for death among ACS patients. Join our expert panel: Profs. Hamm, Kristensen, and Spaulding as they discuss treatment options and strategies to reduce bleeding in STEMI patients.